肺动脉高压初始治疗后随访血流动力学变量的预后价值
本研究基于法国肺动脉高压注册队列中2006至2016年入组的特发性、药物毒物诱发或遗传性PAH患者,评估初始治疗后随访右心导管血流动力学变量的预后价值。主要终点为死亡或肺移植,中位随访2.8年。首次随访右心导管时,NYHA功能分级、6分钟步行距离、每搏输出量指数和右心房压力独立与死亡或肺移植相关,而肺动脉顺应性未独立预测结局。
要点
- 首次随访右心导管时每搏输出量指数和右心房压力独立预测死亡或肺移植。
- 肺动脉顺应性在基线和随访时均未独立预测结局。
- 每搏输出量指数可能是比心指数更合适的治疗目标。
核心结论
- 首次随访右心导管时每搏输出量指数和右心房压力是独立与死亡或肺移植相关的血流动力学变量。
- 每搏输出量指数可能是肺动脉高压比心指数更合适的治疗目标。
研究设计与样本
- 研究纳入2006至2016年法国肺动脉高压注册队列中特发性、药物毒物诱发或遗传性PAH患者,共981例。
- 患者接受基线及随访右心导管检查,主要终点为死亡或肺移植。
- 采用逐步Cox回归和Kaplan-Meier法评估基线和首次随访右心导管变量。
主要发现
- 中位随访2.8年(四分位距1.1-4.6年)期间,331例(33.7%)发生主要终点。
- 仅考虑基线变量的多变量模型中,无血流动力学变量独立预测预后。
- 首次随访右心导管(n=763,中位时间4.6个月,四分位距3.7-7.8个月)时,NYHA功能分级、6分钟步行距离、每搏输出量指数和右心房压力独立与死亡或肺移植相关。
- 每搏输出量指数每降低10 mL/m2的校正风险比为1.28(95%CI 1.11-1.49;P<0.01),右心房压力每升高1 mmHg的校正风险比为1.05(95%CI 1.02-1.09;P<0.01)。
- 在随访时有2个(n=355)或3个(n=193)低风险预后特征(包括心指数≥2.5 L·min-1·m-2、6分钟步行距离>440 m、NYHA I或II级)的患者中,较低的每搏输出量指数仍与较高的死亡或肺移植率相关(P<0.01)。
关键数值与推荐
- 每搏输出量指数每降低10 mL/m2,死亡或肺移植校正风险比1.28(95%CI 1.11-1.49;P<0.01)。
- 右心房压力每升高1 mmHg,死亡或肺移植校正风险比1.05(95%CI 1.02-1.09;P<0.01)。
- 低风险预后特征包括心指数≥2.5 L·min-1·m-2、6分钟步行距离>440 m、NYHA I或II级。
临床怎么用
- 在PAH患者初始治疗后随访右心导管时,应关注每搏输出量指数和右心房压力以评估预后。
- 每搏输出量指数可能作为比心指数更合适的治疗目标,但需进一步验证。
- 肺动脉顺应性不宜作为独立预后指标或治疗目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemodynamic variables such as cardiac index and right atrial pressure have consistently been associated with survival in pulmonary arterial hypertension (PAH) at the time of diagnosis. Recent studies have suggested that pulmonary arterial compliance may also predict prognosis in PAH. The prognostic importance of hemodynamic values achieved after treatment initiation is less well established. METHODS: Our objective was to evaluate the prognostic importance of clinical and hemodynamic variables during follow-up, including pulmonary arterial compliance, after initial management in PAH. We evaluated incident patients with idiopathic, drug- and toxin-induced, or heritable PAH enrolled in the French pulmonary hypertension registry between 2006 and 2016 who had a follow-up right-sided heart catheterization (RHC). The primary outcome was death or lung transplantation. We used stepwise Cox regression and the Kaplan-Meier method to assess variables obtained at baseline and at first follow-up RHC. RESULTS: Of 981 patients, a primary outcome occurred in 331 patients (33.7%) over a median follow-up duration of 2.8 years (interquartile range, 1.1-4.6 years). In a multivariable model considering only baseline variables, no hemodynamic variables independently predicted prognosis. Median time to first follow-up RHC was 4.6 months (interquartile range, 3.7-7.8 months). At first follow-up RHC (n=763), New York Heart Association functional class, 6-minute walk distance, stroke volume index (SVI), and right atrial pressure were independently associated with death or lung transplantation, adjusted for age, sex, and type of PAH. Pulmonary arterial compliance did not independently predict outcomes at baseline or during follow-up. The adjusted hazard ratio for SVI was 1.28 (95% confidence interval, 1.11-1.49; P<0.01) per 10-mL/m2 decrease and for right atrial pressure was 1.05 (95% confidence interval, 1.02-1.09; P<0.01) per 1-mm Hg increase. Among patients who had 2 (n=355) or 3 (n=193) low-risk prognostic features at follow-up, including a cardiac index ≥2.5 L·min-1·m-2, 6-minute walk distance >440 m, and New York Heart Association class I or II functional class, lower SVI was still associated with higher rates of death or lung transplantation (P<0.01). CONCLUSIONS: SVI and right atrial pressure were the hemodynamic variables that were independently associated with death or lung transplantation at first follow-up RHC after initial PAH treatment. These findings suggest that the SVI could be a more appropriate treatment target than cardiac index in PAH.
引用
- Weatherald J, Boucly A, Chemla D, et al. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Circulation. 2017. PMID: 29070502. doi:10.1161/CIRCULATIONAHA.117.029254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。